Congratulations! Innovation is key to biotech industry. Our InnoCare Nanjing R&D Center has been certified as Nanjing Engineering Technology Center through expert review. This is a recognition of the innovation capabilities of InnoCare Nanjing. You can check out our R&D platforms and our research centers in Beijing, Guangzhou and Nanjing. https://lnkd.in/etEXajFT #Innovation
InnoCare Pharma’s Post
More Relevant Posts
-
The Drug Discovery Landscape is Evolving: Are Your Machines Keeping Up?💊💊 The world of pharma is constantly pushing boundaries, developing ever-more complex drugs to combat new and challenging diseases. But are traditional machinery solutions hindering this crucial progress? Here's the reality: Traditional machines may not be equipped to handle the intricate demands of modern drug development. That's where innovation comes in!💥 At Inos Technologies Pvt. Ltd., we believe in designing next-generation machinery that empowers discovery, not restricts it. Our innovative solutions are built to: ✅ Handle the complexities of modern drug development ✅ Increase efficiency and streamline processes ✅ Ultimately, accelerate the path to groundbreaking treatments #EvolvingPharma #InnovationSolution
-
-
I realise this shouldn't be "THIS IS SO CUTE" but.... "THIS IS SO CUTE!!!" - well done Merck Life Science (I am not a process engineer, or a biochemical engineer, so my excitement is very much based on my limited understanding but it looks both really useful and absolutely adorable!) #TechnologyAndInnovation #MerckLifeScience #BiochemicalEngineering
Member of the Executive Board and CEO of Life Science at Merck Group
Some of the most important innovations are also the smallest. Meet the Mobius Breez Microbioreactor, one of the smallest automated perfusion microbioreactor ever created. This innovative microbioreactor helps our customers predict optimum cell culture processes before ramping up production at a larger scale. That helps our customers increase efficiency and reduce development timelines, meaning drugs can move through the development process faster and get to patients even more quickly. Our scientists and engineers tirelessly work to develop novel approaches to our customers' biggest challenges. Even when those challenges only require a “small” innovation, our Merck Life Science colleagues find new ways to create impactful solutions.
-
Reference from Merch life science microbioreactor cell culture in smallest way
Member of the Executive Board and CEO of Life Science at Merck Group
Some of the most important innovations are also the smallest. Meet the Mobius Breez Microbioreactor, one of the smallest automated perfusion microbioreactor ever created. This innovative microbioreactor helps our customers predict optimum cell culture processes before ramping up production at a larger scale. That helps our customers increase efficiency and reduce development timelines, meaning drugs can move through the development process faster and get to patients even more quickly. Our scientists and engineers tirelessly work to develop novel approaches to our customers' biggest challenges. Even when those challenges only require a “small” innovation, our Merck Life Science colleagues find new ways to create impactful solutions.
-
Read the caption!
The Drug Discovery Landscape is Evolving: Are Your Machines Keeping Up?💊💊 The world of pharma is constantly pushing boundaries, developing ever-more complex drugs to combat new and challenging diseases. But are traditional machinery solutions hindering this crucial progress? Here's the reality: Traditional machines may not be equipped to handle the intricate demands of modern drug development. That's where innovation comes in!💥 At Inos Technologies Pvt. Ltd., we believe in designing next-generation machinery that empowers discovery, not restricts it. Our innovative solutions are built to: ✅ Handle the complexities of modern drug development ✅ Increase efficiency and streamline processes ✅ Ultimately, accelerate the path to groundbreaking treatments #EvolvingPharma #InnovationSolution
-
-
Business Development & Strategy | MEng, MBA | Daily impacting life and health with science!
It's a tiny, tiny microbioreactor for perfusion cell culture. Really tiny. Think small working volume but with high throughput. Save on that expensive media you use. 💰 It's set up for automated control and monitoring, so you can do other tasks while it runs efficiently. Or go have a coffee. ☕ It's single-use and fully integrated with hardware and software. That means fast, affordable, flexible and intuitive to use. You'll be savvy in no time. Plus you'll look cool working on it when marcom grabs photos of you in the midst of process development. 😎 See the Mobius® Breez Microbioreactor in action! https://lnkd.in/gvNp5jij
Member of the Executive Board and CEO of Life Science at Merck Group
Some of the most important innovations are also the smallest. Meet the Mobius Breez Microbioreactor, one of the smallest automated perfusion microbioreactor ever created. This innovative microbioreactor helps our customers predict optimum cell culture processes before ramping up production at a larger scale. That helps our customers increase efficiency and reduce development timelines, meaning drugs can move through the development process faster and get to patients even more quickly. Our scientists and engineers tirelessly work to develop novel approaches to our customers' biggest challenges. Even when those challenges only require a “small” innovation, our Merck Life Science colleagues find new ways to create impactful solutions.
-
𝗛𝗶𝗱𝗱𝗲𝗻 𝗧𝗿𝗲𝗮𝘀𝘂𝗿𝗲𝘀: 𝗪𝗵𝘆 𝗕𝗿𝗶𝗹𝗹𝗶𝗮𝗻𝘁 𝗜𝗱𝗲𝗮𝘀 𝗢𝗳𝘁𝗲𝗻 𝗔𝗿𝗲 𝗡𝗼𝘁 𝗥𝗲𝗮𝗹𝗶𝘇𝗲𝗱 We know that brilliant ideas and groundbreaking #technologies often remain hidden, never reaching their full potential. Why? Because realizing these ideas requires collaboration, openness, and the right environment to do so. This is where our commitment to #OpenInnovation and technology transfer comes into play. By embracing an open approach, we’ve successfully transformed two innovative technologies— #PermeaPad and #SpecPlate —into practical solutions that are now making a real impact in the pharmaceutical and biotech industries. Our OpenInnovation approach means: 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗻𝗴 𝗕𝗲𝘆𝗼𝗻𝗱 𝗕𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀: We actively seek partnerships with research institutions, universities, and industry leaders to bring hidden ideas to life. 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗿: We believe in taking promising research out of the lab and into the market, turning concepts into reality. 𝗙𝗼𝗰𝘂𝘀𝗶𝗻𝗴 𝗼𝗻 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲: With PermeaPad and SpecPlate as successful examples, we are continuously looking for new technologies to adopt and develop, ensuring that brilliant ideas are realized and shared with the world. We are committed to uncovering hidden treasures of innovation and turning them into tools that drive scientific progress. #OpenInnovation #TechnologyTransfer #Biotech #Innovation
-
Time and material constraints can be an obstacle to rapid formulation development. Serán BioScience is technology agnostic and seeks to identify the best formulation strategy for your individual program, quickly and with minimal material. Learn more https://hubs.li/Q02h7-DX0 #drugdevelopment
-
-
💥 The Cytocast family has a new member on board; please welcome István Bágyi, our Innovation and Grant Coordinator, from now on. 🚀 István has strong industrial and research experience in Europe and the USA. He is an innovation manager and granting specialist with proven skills in the chemical industry, drug discovery and development, biotechnology, nanotechnology, electric technology and software development. He routinely prepares grant proposals and coordinates national and international interdisciplinary R&D projects and high-tech innovations. He is also a legal and compliance professional in the software industry with broad experience supporting C-suite-level stakeholders. His expertise and skillset will help us find new opportunities (and challenges 😊), shaping the future of Cytocast. #CytocastSimulatedCell #Innovation
-
-
Congress's scrutiny of WuXi AppTec underscores the tension between national security and economic growth. With the BIOSECURE Act threatening WuXi's Middletown pharma campus, critical questions arise: ▪️ How do we balance economic interests with security concerns? ▪️ What might be the local economic impact in Delaware? ▪️ How could this affect the broader U.S. biotech sector? #Biotech #EconomicDevelopment #NationalSecurity
-
If you want drug therapies with fewer side effects, water bottles without toxic nanoplastics, or a more energy-efficient car without the high price tag, get excited! This #OrigiGator startup is commercializing research by Adam Veige, a recipient of a UF Innovate #StandingInnOvation2023 #InventionoftheYear award. Oboro Labs plans to forever alter the way manufacturers produce almost everything — because the cyclic polymers it is licensing don't break down like typical polymers. (It's a bit complicated, but the results are powerful!) Learn more, here. ▶️ https://lnkd.in/erNiMM_R
-
